The hepatitis C virus internal ribosome entry site facilitates efficient protein synthesis in blood vessel endothelium during tumour angiogenesis.
The development of gene delivery systems for therapeutic use involves vectors (often retrovirus or adenovirus) which typically encode one target protein, but the use of internal ribosome entry sites (IRES) can confer the ability to express more than one protein from bi- or polycistronic mRNAs. IRES...
Main Authors: | Chung, G, Yamada, Y, Pannell, R, Forster, A, Rabbitts, T |
---|---|
格式: | Journal article |
语言: | English |
出版: |
2003
|
相似书籍
-
The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
由: Yamada, Y, et al.
出版: (2002) -
The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
由: Yamada, Y, et al.
出版: (2000) -
RNA-Protein Interactome at the Hepatitis E Virus Internal Ribosome Entry Site
由: Shiv Kumar, et al.
出版: (2023-08-01) -
IRESpy: an XGBoost model for prediction of internal ribosome entry sites
由: Junhui Wang, et al.
出版: (2019-07-01) -
Polypyrimidine-Tract-Binding Protein Isoforms Differentially Regulate the Hepatitis C Virus Internal Ribosome Entry Site
由: Jenniffer Angulo, et al.
出版: (2022-12-01)